8-K Announcements
6Apr 9, 2026·SEC
Mar 16, 2026·SEC
Mar 13, 2026·SEC
Science Applications International Corporation (SAIC) fundamental analysis — strengths, weaknesses & financial health based on data analysis
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Science Applications International Corporation (SAIC) stock price & volume — 10-year historical chart
Science Applications International Corporation (SAIC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Science Applications International Corporation (SAIC) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 16, 2026 | $2.62vs $2.31+13.4% | $1.8Bvs $1.8B-0.1% |
| Q4 2025 | Dec 4, 2025 | $2.58vs $2.07+24.6% | $1.9Bvs $1.9B-0.1% |
| Q4 2025 | Sep 4, 2025 | $2.71 | $1.8B |
| Q3 2025 | Jun 2, 2025 | $1.92vs $2.14-10.3% | $1.9Bvs $1.9B+0.5% |
Science Applications International Corporation (SAIC) competitors in Government and Defense IT Services — business model, growth, and fundamentals comparison
Science Applications International Corporation (SAIC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Science Applications International Corporation (SAIC) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Jan'18 | Jan'19 | Jan'20 | Jan'21 | Jan'22 | Jan'23 | Jan'24 | Jan'25 | Jan'26 |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 4.45B | 4.66B | 6.38B | 7.06B | 7.39B | 7.7B | 7.44B | 7.48B | 7.26B |
| Revenue Growth % | 0.27% | 4.6% | 36.92% | 10.61% | 4.79% | 4.19% | -3.37% | 0.47% | -2.9% |
| Cost of Goods Sold | 4.04B | 4.2B | 5.67B | 6.26B | 6.54B | 6.82B | 6.57B | 6.59B | 6.39B |
| COGS % of Revenue | 90.77% | 90.04% | 88.93% | 88.78% | 88.38% | 88.47% | 88.29% | 88.07% | 87.99% |
| Gross Profit | 411M▲ 0% | 464M▲ 12.9% | 706M▲ 52.2% | 792M▲ 12.2% | 859M▲ 8.5% | 888M▲ 3.4% | 872M▼ 1.8% | 892M▲ 2.3% | 872M▼ 2.2% |
| Gross Margin % | 9.23% | 9.96% | 11.07% | 11.22% | 11.62% | 11.53% | 11.71% | 11.93% | 12.01% |
| Gross Profit Growth % | -6.38% | 12.9% | 52.16% | 12.18% | 8.46% | 3.38% | -1.8% | 2.29% | -2.24% |
| Operating Expenses | 155M | 244M | 336M | 402M | 397M | 387M | 131M | 329M | 357M |
| OpEx % of Revenue | 3.48% | 5.24% | 5.27% | 5.7% | 5.37% | 5.02% | 1.76% | 4.4% | 4.92% |
| Selling, General & Admin | 151M | 153M | 281M | 346M | 340M | 373M | 369M | 327M | 356M |
| SG&A % of Revenue | 3.39% | 3.28% | 4.41% | 4.9% | 4.6% | 4.84% | 4.96% | 4.37% | 4.9% |
| Research & Development | 4M | 5M | 7M | 6M | 4M | 1M | 4M | 12M | 0 |
| R&D % of Revenue | 0.09% | 0.11% | 0.11% | 0.08% | 0.05% | 0.01% | 0.05% | 0.16% | - |
| Other Operating Expenses | 0 | 86M | 48M | 50M | 53M | 13M | -242M | -10M | 1M |
| Operating Income | 256M▲ 0% | 220M▼ 14.1% | 370M▲ 68.2% | 390M▲ 5.4% | 462M▲ 18.5% | 501M▲ 8.4% | 741M▲ 47.9% | 563M▼ 24.0% | 515M▼ 8.5% |
| Operating Margin % | 5.75% | 4.72% | 5.8% | 5.53% | 6.25% | 6.5% | 9.95% | 7.53% | 7.09% |
| Operating Income Growth % | -2.66% | -14.06% | 68.18% | 5.41% | 18.46% | 8.44% | 47.9% | -24.02% | -8.53% |
| EBITDA | 302M | 267M | 501M | 569M | 627M | 658M | 883M | 703M | 664M |
| EBITDA Margin % | 6.78% | 5.73% | 7.85% | 8.06% | 8.48% | 8.54% | 11.86% | 9.4% | 9.14% |
| EBITDA Growth % | -4.43% | -11.59% | 87.64% | 13.57% | 10.19% | 4.94% | 34.19% | -20.39% | -5.55% |
| D&A (Non-Cash Add-back) | 46M | 47M | 131M | 179M | 165M | 157M | 142M | 140M | 149M |
| EBIT | 258M | 223M | 376M | 393M | 463M | 493M | 740M | 554M | 515M |
| Net Interest Income | -44M | -53M | -90M | -122M | -105M | -118M | -120M | -126M | -128M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 44M | 53M | 90M | 122M | 105M | 118M | 120M | 126M | 128M |
| Other Income/Expense | -42M | -50M | -84M | -119M | -104M | -126M | -121M | -135M | -128M |
| Pretax Income | 214M▲ 0% | 170M▼ 20.6% | 286M▲ 68.2% | 271M▼ 5.2% | 358M▲ 32.1% | 375M▲ 4.7% | 620M▲ 65.3% | 428M▼ 31.0% | 387M▼ 9.6% |
| Pretax Margin % | 4.8% | 3.65% | 4.48% | 3.84% | 4.84% | 4.87% | 8.33% | 5.72% | 5.33% |
| Income Tax | 35M | 33M | 57M | 60M | 79M | 72M | 143M | 66M | 29M |
| Effective Tax Rate % | 16.36% | 19.41% | 19.93% | 22.14% | 22.07% | 19.2% | 23.06% | 15.42% | 7.49% |
| Net Income | 179M▲ 0% | 137M▼ 23.5% | 226M▲ 65.0% | 209M▼ 7.5% | 277M▲ 32.5% | 300M▲ 8.3% | 477M▲ 59.0% | 362M▼ 24.1% | 358M▼ 1.1% |
| Net Margin % | 4.02% | 2.94% | 3.54% | 2.96% | 3.75% | 3.89% | 6.41% | 4.84% | 4.93% |
| Net Income Growth % | 25.17% | -23.46% | 64.96% | -7.52% | 32.54% | 8.3% | 59% | -24.11% | -1.1% |
| Net Income (Continuing) | 179M | 137M | 229M | 211M | 279M | 303M | 477M | 362M | 358M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 14M | 10M | 10M | 10M | 10M | 0 | 0 | 0 |
| EPS (Diluted) | 4.02▲ 0% | 3.11▼ 22.6% | 3.83▲ 23.2% | 3.56▼ 7.0% | 4.77▲ 34.0% | 5.38▲ 12.8% | 8.88▲ 65.1% | 7.17▼ 19.3% | 7.70▲ 7.4% |
| EPS Growth % | 28.85% | -22.64% | 23.15% | -7.05% | 33.99% | 12.79% | 65.06% | -19.26% | 7.39% |
| EPS (Basic) | 4.13 | 3.16 | 3.87 | 3.60 | 4.81 | 5.43 | 8.98 | 7.23 | 7.73 |
| Diluted Shares Outstanding | 44.5M | 44.1M | 59M | 58.7M | 58.1M | 55.8M | 53.7M | 50.5M | 46.5M |
| Basic Shares Outstanding | 43.3M | 43.4M | 58.4M | 58.1M | 57.6M | 55.3M | 53.1M | 50.1M | 46.3M |
| Dividend Payout Ratio | 30.17% | 38.69% | 38.5% | 41.63% | 31.05% | 27.67% | 16.56% | 20.72% | 19.55% |
Science Applications International Corporation (SAIC) balance sheet — assets, liabilities & shareholders' equity
| Line item | Jan'18 | Jan'19 | Jan'20 | Jan'21 | Jan'22 | Jan'23 | Jan'24 | Jan'25 | Jan'26 |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 950M | 1.43B | 1.43B | 1.29B | 1.26B | 1.2B | 1.13B | 1.15B | 1.18B |
| Cash & Short-Term Investments | 144M | 237M | 188M | 171M | 106M | 109M | 94M | 56M | 182M |
| Cash Only | 144M | 237M | 188M | 171M | 106M | 109M | 94M | 56M | 182M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 674M | 1.05B | 1.1B | 962M | 1.01B | 936M | 914M | 1B | 853M |
| Days Sales Outstanding | 55.23 | 82.26 | 62.88 | 49.76 | 50.1 | 44.35 | 44.82 | 48.8 | 42.87 |
| Inventory | 132M | 74M | 143M | 156M | 142M | 152M | 3M | 0 | 0 |
| Days Inventory Outstanding | 11.92 | 6.44 | 9.2 | 9.09 | 7.93 | 8.14 | 0.17 | - | - |
| Other Current Assets | 64M | 25M | 19M | 22M | 21M | 23M | 27M | 20M | 144M |
| Total Non-Current Assets | 1.12B | 3.13B | 3.28B | 4.43B | 4.48B | 4.69B | 4.18B | 4.09B | 4.17B |
| Property, Plant & Equipment | 61M | 103M | 281M | 344M | 309M | 250M | 243M | 268M | 303M |
| Fixed Asset Turnover | 73.02x | 45.23x | 22.70x | 20.51x | 23.93x | 30.82x | 30.63x | 27.91x | 23.97x |
| Goodwill | 863M | 2.12B | 2.14B | 2.79B | 2.91B | 2.91B | 2.85B | 2.85B | 2.94B |
| Intangible Assets | 179M | 803M | 711M | 1.14B | 1.13B | 1.01B | 894M | 779M | 761M |
| Long-Term Investments | 0 | 0 | 0 | 27M | 28M | 72M | 0 | 91M | 46M |
| Other Non-Current Assets | 11M | 29M | 76M | 73M | 84M | 97M | 167M | 103M | 121M |
| Total Assets | 2.07B▲ 0% | 4.56B▲ 120.1% | 4.71B▲ 3.2% | 5.72B▲ 21.5% | 5.75B▲ 0.4% | 5.54B▼ 3.5% | 5.31B▼ 4.1% | 5.25B▼ 1.3% | 5.35B▲ 2.1% |
| Asset Turnover | 2.15x | 1.02x | 1.35x | 1.23x | 1.29x | 1.39x | 1.40x | 1.43x | 1.36x |
| Asset Growth % | 1.52% | 120.12% | 3.24% | 21.48% | 0.4% | -3.53% | -4.13% | -1.28% | 2.06% |
| Total Current Liabilities | 695M | 897M | 1.13B | 1.27B | 1.35B | 1.13B | 1.16B | 1.4B | 982M |
| Accounts Payable | 397M | 455M | 527M | 517M | 612M | 624M | 567M | 631M | 500M |
| Days Payables Outstanding | 35.84 | 39.59 | 33.91 | 30.13 | 34.18 | 33.42 | 31.49 | 34.97 | 28.56 |
| Short-Term Debt | 41M | 24M | 70M | 68M | 148M | 31M | 77M | 313M | 40M |
| Deferred Revenue (Current) | 23M | -201M | 41M | 82M | 55M | 48M | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 442M |
| Current Ratio | 1.37x | 1.60x | 1.27x | 1.01x | 0.93x | 1.06x | 0.98x | 0.83x | 1.20x |
| Quick Ratio | 1.18x | 1.52x | 1.14x | 0.89x | 0.83x | 0.93x | 0.97x | 0.83x | 1.20x |
| Cash Conversion Cycle | 31.31 | 49.11 | 38.18 | 28.73 | 23.85 | 19.07 | 13.49 | - | - |
| Total Non-Current Liabilities | 1.05B | 2.17B | 2.16B | 2.9B | 2.77B | 2.71B | 2.37B | 2.27B | 2.87B |
| Long-Term Debt | 983M | 2.06B | 1.85B | 2.45B | 2.37B | 2.34B | 2.02B | 1.91B | 2.47B |
| Capital Lease Obligations | 0 | 0 | 172M | 205M | 192M | 152M | 147M | 173M | 198M |
| Deferred Tax Liabilities | 23M | 0 | 0 | 2M | 43M | 0 | 0 | 24M | 104M |
| Other Non-Current Liabilities | 45M | 96M | 123M | 227M | 151M | 214M | 202M | 169M | 100M |
| Total Liabilities | 1.75B | 3.06B | 3.28B | 4.17B | 4.12B | 3.84B | 3.53B | 3.67B | 3.85B |
| Total Debt | 1.02B | 2.09B | 2.09B | 2.72B | 2.71B | 2.53B | 2.25B | 2.39B | 217M |
| Net Debt | 880M | 1.85B | 1.91B | 2.55B | 2.6B | 2.42B | 2.15B | 2.34B | 35M |
| Debt / Equity | 3.13x | 1.38x | 1.47x | 1.75x | 1.66x | 1.48x | 1.26x | 1.52x | 0.14x |
| Debt / EBITDA | 3.39x | 7.82x | 4.18x | 4.78x | 4.32x | 3.84x | 2.54x | 3.40x | 0.33x |
| Net Debt / EBITDA | 2.91x | 6.94x | 3.80x | 4.48x | 4.15x | 3.67x | 2.44x | 3.32x | 0.05x |
| Interest Coverage | 5.82x | 4.15x | 4.11x | 3.20x | 4.40x | 4.25x | 6.18x | 4.47x | 4.02x |
| Total Equity | 327M▲ 0% | 1.51B▲ 362.7% | 1.43B▼ 5.6% | 1.55B▲ 8.7% | 1.63B▲ 5.0% | 1.7B▲ 4.6% | 1.78B▲ 4.8% | 1.58B▼ 11.7% | 1.5B▼ 4.9% |
| Equity Growth % | -6.3% | 362.69% | -5.62% | 8.68% | 4.96% | 4.6% | 4.75% | -11.65% | -4.88% |
| Book Value per Share | 7.35 | 34.31 | 24.20 | 26.44 | 28.04 | 30.54 | 33.24 | 31.23 | 32.26 |
| Total Shareholders' Equity | 327M | 1.5B | 1.42B | 1.54B | 1.62B | 1.69B | 1.78B | 1.58B | 1.5B |
| Common Stock | 0 | 0 | 0 | 0 | 1.62B | 1.69B | 0 | 0 | 0 |
| Retained Earnings | 323M | 367M | 506M | 627M | 818M | 1.03B | 1.43B | 1.56B | 1.49B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 4M | -14M | -72M | -89M | -37M | 22M | 16M | 12M | 8M |
| Minority Interest | 0 | 14M | 10M | 10M | 10M | 10M | 0 | 0 | 0 |
Science Applications International Corporation (SAIC) cash flow — operating, investing & free cash flow history
| Line item | Jan'18 | Jan'19 | Jan'20 | Jan'21 | Jan'22 | Jan'23 | Jan'24 | Jan'25 | Jan'26 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 217M | 184M | 458M | 755M | 518M | 532M | 396M | 494M | 609M |
| Operating CF Margin % | 4.87% | 3.95% | 7.18% | 10.7% | 7.01% | 6.91% | 5.32% | 6.61% | 8.39% |
| Operating CF Growth % | -20.51% | -15.21% | 148.91% | 64.85% | -31.39% | 2.7% | -25.56% | 24.75% | 23.28% |
| Net Income | 179M | 137M | 229M | 211M | 279M | 303M | 477M | 362M | 358M |
| Depreciation & Amortization | 46M | 49M | 138M | 179M | 165M | 157M | 142M | 140M | 149M |
| Stock-Based Compensation | 27M | 45M | 37M | 42M | 46M | 48M | 68M | 53M | 64M |
| Deferred Taxes | 13M | 19M | 44M | 12M | 59M | -17M | -17M | -3M | 81M |
| Other Non-Cash Items | 184M | 40M | 5M | 18M | -10M | -1M | -253M | -7M | 1M |
| Working Capital Changes | -48M | -106M | 5M | 293M | -21M | 42M | -21M | -51M | -44M |
| Change in Receivables | -135M | -4M | -43M | 221M | -31M | 79M | -46M | -86M | 161M |
| Change in Inventory | 19M | -26M | -10M | 8M | 14M | 0 | -43M | 0 | 0 |
| Change in Payables | 68M | -65M | 62M | -76M | 30M | -9M | 13M | 48M | -101M |
| Cash from Investing | -22M | -1.03B | -47M | -1.23B | -292M | -36M | 314M | -35M | -248M |
| Capital Expenditures | -22M | -28M | -21M | -46M | -36M | -25M | -27M | -36M | 0 |
| CapEx % of Revenue | 0.49% | 0.6% | 0.33% | 0.65% | 0.49% | 0.32% | 0.36% | 0.48% | 0.44% |
| Acquisitions | 0 | -1B | 0 | -1.19B | -247M | 0 | 348M | 10M | -203M |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | -22M | 1M | -5M | -3M | -6M | -8M | -5M | -7M | -32M |
| Cash from Financing | -261M | 938M | -455M | 464M | -301M | -493M | -725M | -498M | -235M |
| Debt Issued (Net) | -25M | 1.08B | -174M | 601M | -3M | -150M | -281M | 118M | 262M |
| Equity Issued (Net) | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K |
| Dividends Paid | -54M | -53M | -87M | -87M | -86M | -83M | -79M | -75M | -70M |
| Share Repurchases | -186M | -69M | -197M | -34M | -226M | -267M | -382M | -558M | -445M |
| Other Financing | -2M | -27M | -7M | -29M | -2M | -9M | -663M | -3M | -4M |
| Net Change in Cash | -66M▲ 0% | 94M▲ 242.4% | -44M▼ 146.8% | -12M▲ 72.7% | -75M▼ 525.0% | 3M▲ 104.0% | -15M▼ 600.0% | -39M▼ 160.0% | 126M▲ 423.1% |
| Free Cash Flow | 195M▲ 0% | 156M▼ 20.0% | 437M▲ 180.1% | 709M▲ 62.2% | 482M▼ 32.0% | 507M▲ 5.2% | 369M▼ 27.2% | 458M▲ 24.1% | 577M▲ 26.0% |
| FCF Margin % | 4.38% | 3.35% | 6.85% | 10.05% | 6.52% | 6.58% | 4.96% | 6.12% | 7.95% |
| FCF Growth % | -24.42% | -20% | 180.13% | 62.24% | -32.02% | 5.19% | -27.22% | 24.12% | 25.98% |
| FCF per Share | 4.38 | 3.54 | 7.41 | 12.08 | 8.30 | 9.09 | 6.87 | 9.07 | 12.41 |
| FCF Conversion (FCF/Net Income) | 1.21x | 1.34x | 2.03x | 3.61x | 1.87x | 1.77x | 0.83x | 1.36x | 1.70x |
| Interest Paid | 41M | 44M | 86M | 96M | 98M | 111M | 125M | 121M | 0 |
| Taxes Paid | 31M | 24M | 32M | 39M | 7M | 70M | 165M | 66M | 0 |
Science Applications International Corporation (SAIC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 39.23% | 52.96% | 14.89% | 15.37% | 14.03% | 17.42% | 18% | 27.34% | 21.53% | 23.27% |
| Return on Invested Capital (ROIC) | 16.16% | 16.05% | 7.22% | 8.29% | 7.87% | 8.32% | 9% | 13.79% | 10.76% | 14.18% |
| Gross Margin | 9.88% | 9.23% | 9.96% | 11.07% | 11.22% | 11.62% | 11.53% | 11.71% | 11.93% | 12.01% |
| Net Margin | 3.22% | 4.02% | 2.94% | 3.54% | 2.96% | 3.75% | 3.89% | 6.41% | 4.84% | 4.93% |
| Debt / Equity | 3.00x | 3.13x | 1.38x | 1.47x | 1.75x | 1.66x | 1.48x | 1.26x | 1.52x | 0.14x |
| Interest Coverage | 5.06x | 5.82x | 4.15x | 4.11x | 3.20x | 4.40x | 4.25x | 6.18x | 4.47x | 4.02x |
| FCF Conversion | 1.91x | 1.21x | 1.34x | 2.03x | 3.61x | 1.87x | 1.77x | 0.83x | 1.36x | 1.70x |
| Revenue Growth | 2.94% | 0.27% | 4.6% | 36.92% | 10.61% | 4.79% | 4.19% | -3.37% | 0.47% | -2.9% |
Science Applications International Corporation (SAIC) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 9, 2026·SEC
Mar 16, 2026·SEC
Mar 13, 2026·SEC
Science Applications International Corporation (SAIC) stock FAQ — growth, dividends, profitability & financials explained
Science Applications International Corporation (SAIC) reported $7.26B in revenue for fiscal year 2026. This represents a 33% decrease from $10.80B in 2011.
Science Applications International Corporation (SAIC) saw revenue decline by 2.9% over the past year.
Yes, Science Applications International Corporation (SAIC) is profitable, generating $358.0M in net income for fiscal year 2026 (4.9% net margin).
Yes, Science Applications International Corporation (SAIC) pays a dividend with a yield of 1.60%. This makes it attractive for income-focused investors.
Science Applications International Corporation (SAIC) has a return on equity (ROE) of 23.3%. This is excellent, indicating efficient use of shareholder capital.
Science Applications International Corporation (SAIC) generated $609.0M in free cash flow for fiscal year 2026. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Science Applications International Corporation (SAIC) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates